Arvinas (ARVN) Operating Leases (2019 - 2026)

Arvinas (ARVN) posted quarterly Operating Leases of $8.1 million for Q1 2026, down 19.0% year-over-year from $10.0 million in Q1 2025, and up 19.12% quarter-over-quarter from $6.8 million in Q4 2025.

Arvinas (ARVN) Operating Leases (2019 - 2026) Analysis & Trends

Arvinas' Operating Leases history runs 8 years deep, the most recent figure standing at $8.1 million for Q1 2026.

  • In Q1 2026, Operating Leases fell 19.0% year-over-year to $8.1 million; the TTM figure through Mar 2026 stood at $8.1 million (down 19.0% YoY), while the FY2025 annual figure was $6.8 million, down 6.85% from the prior year.
  • Operating Leases for Q1 2026 stood at $8.1 million, up from $6.8 million in the prior quarter.
  • The five-year high for Operating Leases was $10.0 million in Q1 2025, with the low at $200000.0 in Q2 2024.
  • The 5-year median for Operating Leases is $3.5 million (2023), against an average of $4.3 million.
  • The sharpest annual moves came in 2024 and 2025: Operating Leases tumbled 94.29% in 2024, then soared 3700.0% in 2025.
  • Arvinas' Operating Leases stood at $2.7 million in 2022, then tumbled by 81.48% to $500000.0 in 2023, then soared by 1360.0% to $7.3 million in 2024, then fell by 6.85% to $6.8 million in 2025, then rose by 19.12% to $8.1 million in 2026.
  • Business Quant data shows ARVN's Operating Leases at $8.1 million in Q1 2026, $6.8 million in Q4 2025, and $7.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Arvinas 585.74 Mn 17.84 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 7.70 Mn
Mar 31, 2026 8.10 Mn
Dec 31, 2025 6.80 Mn
Sep 30, 2025 7.20 Mn
Jun 30, 2025 7.60 Mn
Mar 31, 2025 10.00 Mn
Dec 31, 2024 7.30 Mn
Sep 30, 2024 900,000.00
Jun 30, 2024 200,000.00
Mar 31, 2024 1.90 Mn
Dec 31, 2023 500,000.00
Sep 30, 2023 3.00 Mn
Jun 30, 2023 3.50 Mn
Mar 31, 2023 2.10 Mn
Dec 31, 2022 2.70 Mn
Sep 30, 2022 3.10 Mn
Jun 30, 2022 3.60 Mn
Mar 31, 2022 4.10 Mn
Dec 31, 2021 2.90 Mn
Sep 30, 2021 3.19 Mn